NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluating NBTXR3 for the Treatment of Head and Neck Cancer
Regional activation for Nanobiotix pivotal Phase 3 trial in head and neck cancer proceeds as…
Regional activation for Nanobiotix pivotal Phase 3 trial in head and neck cancer proceeds as…
BRISBANE, Australia--(BUSINESS WIRE)--GE Aviation announced the opening a new state-of-the-art facility in Australia to provide…
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--$RDY #Affordablemedicines--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE:…
DUBLIN--(BUSINESS WIRE)--The "Global Personal Flotation Devices Market 2022-2026" report has been added to ResearchAndMarkets.com's offering.…
SINGAPORE--(BUSINESS WIRE)--Atlas Technology (Atlas), a business-to-protocol innovator who provides a full suite of infrastructure for…
Liquidnet’s VWAP Cross brings pre-market trading capability to Hong Kong, Japan and Australia HONG KONG--(BUSINESS…
DUBLIN--(BUSINESS WIRE)--The "Eye Care Products Markets in China" report has been added to ResearchAndMarkets.com's offering.…
KUALA LUMPUR, MALAYSIA - Media OutReach - 7 September 2022 - Choosing a reliable broker…
Company Expects Phase 2 Data with Second Drug Candidate (CST-103) in Neurodegenerative Diseases in Third…
PS8570 Enables Low Power Operation and Flexible Interconnect SAN JOSE, Calif.--(BUSINESS WIRE)--Parade Technologies, Ltd. (Taiwan…